Combating challenges in CAR-T cells with engineering immunology

Chimeric antigen receptors (CAR) T cells (CAR-T) mark a significant step towards producing safe and effective personal anticancer treatments. CAR-T strategies engineers the T cells from the patients to allow specific binding to a tumour-specific antigen. CAR-Ts are a second-wave offensive strategy t...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Clement Yisai, Ting Cheung, Stephanie Po, Sugimura, Ryohichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589253/
https://www.ncbi.nlm.nih.gov/pubmed/36299480
http://dx.doi.org/10.3389/fcell.2022.969020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589253/
https://www.ncbi.nlm.nih.gov/pubmed/36299480
http://dx.doi.org/10.3389/fcell.2022.969020

Ejemplares similares